Subsense, an AI-native neurotechnology company, has announced a major expansion of its AI-driven NanoBCI strategy, combining AI, nanotechnology and neural interfaces to develop a non-surgical brain-computer interface. Unlike approaches that rely on implanted hardware or external skull-based sensing, Subsense is developing a nanoparticle-based interface intended to eventually read or stimulate neural activity without permanently implanted electrodes. The company says it is developing the first AI-native NanoBCI.
Key takeaways
- AI is applied upstream in materials development to design, score and evaluate nanoparticle candidates and model their navigation to specific brain areas, rather than only analyzing neural data after collection.
- Subsense has built an integrated computational workflow that ranks magnetoelectric nanoparticle candidates across five coupled dimensions: colloidal stability, core magnetostriction, shell piezoelectric response, core-shell interface strain transfer and biocompatibility, supported by 2D and 3D physics simulations of nanoparticle navigation.
- For stimulation, the company is developing magnetoelectric nanoparticles that respond to externally generated magnetic fields to produce localized electrical effects; for neural reading, it is studying plasmonic nanoparticles intended to generate optical signals detectable by external hardware.
- Subsense has been awarded $250,000 in Google Cloud credits to scale computational workflows and broaden nanoparticle design exploration.
- The company remains preclinical and is engaging with the US FDA while advancing separate stimulation and reading programs toward a possible combined platform.
For manufacturing automation, the program illustrates how AI-driven computational screening can prioritize complex material candidates before physical synthesis and testing, a workflow pattern relevant to advanced materials and precision component development.
Source: Robotics & Automation News · Published 2026-09-18T17:16:40 · “Subsense develops AI-powered nanoparticle brain-computer interface without implanted electrodes”